Host: John J. Russell, MD 


  Guest: Drew Weissman, MD, PhD 


  Guest: Katalin Karikó, PhD 



  
    As mRNA technology continues to emerge and evolve, Penn Researchers Dr. Drew Weissman and Dr. Katalin Karikó join Dr. John Russell to take a deep dive into the future of mRNA technology.

Breaking Through Barriers: Meet the Minds Behind Emerging mRNA Technology

Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Host: Jennifer Caudle, DO 


  Guest: Roy Rosin, MBA 


  Guest: Shivan Mehta, MD, MBA, MSHP 



  
    From home care to cancer screening, what are some of the top initiatives in patient care at Penn Medicine’s new Acceleration Lab? Mr. Roy Rosin and Dr. Shivan Mehta sit down with Dr. Jennifer Caudle to share the latest updates from the Acceleration Lab.

The Acceleration Lab: Key Initiatives in Patient-Centered Care

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: Kirstin Leitner, MD 



  
    Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.

Healing at Home: Advancements in Screening for Postpartum Depression

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: Elise Chong, MD 



  
    Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.

Considering CAR T-cell Therapy in Follicular Lymphoma

Host: Charles Turck, PharmD, BCPS, BCCCP 


  Guest: Janos L. Tanyi, MD, PhD 



  
    Recently the FDA approved a “Glowing Tumor” imaging drug to help oncologists better identify ovarian cancer cells using an approach pioneered by surgeons at Penn Medicine. Joining Dr. Charles Turck to discuss this recent approval and fluorescence-guided, intraoperative imaging is Dr. Janos Tanyi, Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania.

Breaking Through Barriers: Meet the Minds Behind Emerging mRNA Technology

Download our free app to listen on your phone